The AHDC1 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout population derived from the HeLa cell line, designed for targeted disruption of the AHDC1 gene. This loss-of-function model enables investigation of AHDC1-dependent chromatin regulation and transcriptional control in a human epithelial context. The polyclonal composition encompasses a heterogeneous pool of edited alleles, offering a robust system for functional genomic screens and pathway dissection without clonal selection bias.
The host HeLa cell line is an immortalized epithelial cell model originating from cervical adenocarcinoma tissue, positive for human papillomavirus type 18 (HPV18). Its robust growth characteristics, well-characterized molecular landscape, and extensive history of use in cancer research make it a versatile platform for studying gene function in chromatin dynamics, cell cycle regulation, and oncogenic signaling.
AHDC1 functions as a chromatin-binding protein that interacts with the nucleosome remodeling and deacetylase (NuRD) complex, including core components CHD4, HDAC1, and HDAC2. Through these interactions, AHDC1 contributes to histone deacetylation and chromatin remodeling, thereby regulating transcriptional programs. The precise upstream signals that control AHDC1 activity remain unknown, but its association with the NuRD complex positions it as a key node in gene silencing mechanisms. Downstream targets are also undefined, underscoring the need for systematic profiling in this knockout model.
Disruption of AHDC1 in the HeLa epithelial background offers a valuable system to dissect the functional consequences of compromised NuRD complex activity. In this context, loss of AHDC1 may perturb the balance of histone acetylation and chromatin accessibility, influencing gene expression programs related to cell cycle control, apoptosis, or epithelial identity. Although AHDC1 mutations are causally linked to Xia-Gibbs syndrome, a neurodevelopmental disorder, studying its function in a non-neuronal cell line can uncover fundamental chromatin regulatory mechanisms that may inform broader principles of transcriptional dysregulation in disease.
Researchers can employ this knockout model for functional genomics studies of chromatin regulators, including co-immunoprecipitation to probe NuRD complex integrity, ChIP-qPCR to assess histone modification changes, and RNA-seq to uncover transcriptional alterations. Additional applications include drug target validation for neurodevelopmental disorders and reporter gene assays to evaluate AHDC1-dependent gene regulation. For further details and technical support, please contact Ascent Research.
